TNFSF10 and granular cell tumor: Interestingly, normal granulosa cells and most GCTs express DR4/5 [1,22] and the GCT model cell line KGN is reported to be sensitized to TRAIL in vitro when combined with cisplatin, proteasome inhibitors, or mitochondrial membrane potential uncouplers [23,24].